Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca L Riding

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2019
The Role of Memory CD8<sup>+</sup> T Cells in VitiligoRebecca L Riding, John E Harris
Current Protocols in Immunology|September 26, 2018
Mouse Model for Human VitiligoRebecca L Riding, Jillian M Richmond, John E Harris
Pigment Cell & Melanoma Research|October 11, 2020
Type I interferon signaling limits viral vector priming of CD8<sup>+</sup> T cells during initiation of vitiligo and melanoma immunotherapyRebecca L Riding, Jillian M Richmond, Keitaro Fukuda, et al.
The Journal of Investigative Dermatology|July 5, 2022
A Keratinocyte-Tethered Biologic Enables Location-Precise Treatment in Mouse VitiligoYing-Chao Hsueh, Yuzhen Wang, Rebecca L Riding, et al.
Plos One|January 10, 2013
Retrotransposon insertion in the T-cell acute lymphocytic leukemia 1 (Tal1) gene is associated with severe renal disease and patchy alopecia in Hairpatches (Hpt) miceVishnu Hosur, Melissa L Cox, Lisa M Burzenski, et al.
Science Translational Medicine|July 20, 2018
Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligoJillian M Richmond, James P Strassner, Lucio Zapata, et al.
The Journal of Experimental Medicine|July 29, 2021
AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanomaKeitaro Fukuda, Ken Okamura, Rebecca L Riding, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2019
The Role of Memory CD8<sup>+</sup> T Cells in VitiligoRebecca L Riding, John E Harris
Current Protocols in Immunology|September 26, 2018
Mouse Model for Human VitiligoRebecca L Riding, Jillian M Richmond, John E Harris
Pigment Cell & Melanoma Research|October 11, 2020
Type I interferon signaling limits viral vector priming of CD8<sup>+</sup> T cells during initiation of vitiligo and melanoma immunotherapyRebecca L Riding, Jillian M Richmond, Keitaro Fukuda, et al.
The Journal of Investigative Dermatology|July 5, 2022
A Keratinocyte-Tethered Biologic Enables Location-Precise Treatment in Mouse VitiligoYing-Chao Hsueh, Yuzhen Wang, Rebecca L Riding, et al.
Plos One|January 10, 2013
Retrotransposon insertion in the T-cell acute lymphocytic leukemia 1 (Tal1) gene is associated with severe renal disease and patchy alopecia in Hairpatches (Hpt) miceVishnu Hosur, Melissa L Cox, Lisa M Burzenski, et al.
Science Translational Medicine|July 20, 2018
Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligoJillian M Richmond, James P Strassner, Lucio Zapata, et al.
The Journal of Experimental Medicine|July 29, 2021
AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanomaKeitaro Fukuda, Ken Okamura, Rebecca L Riding, et al.
Pageof 1